NF-κB 발현을 인간 피부세포에서 정량적으로 측정하기위한 안정한 분석시스템 및 그의 용도
    1.
    发明公开
    NF-κB 발현을 인간 피부세포에서 정량적으로 측정하기위한 안정한 분석시스템 및 그의 용도 失效
    用于定量测定人皮肤细胞中NF-B表达的稳定系统及其用途

    公开(公告)号:KR1020020040494A

    公开(公告)日:2002-05-30

    申请号:KR1020000070557

    申请日:2000-11-24

    CPC classification number: C12N15/65 C12Q2600/158

    Abstract: PURPOSE: Provided are stable system for quantitative determination of NF-kappa B expression in human skin cells and its use in screening skin whitening agents, anti-inflammatory agents or anti-oxidants. The analytical system uses fluorescent substrate to make it very sensitive and simple and is used effectively in screening skin whitening agents, anti-inflammatory agents or anti-oxidants in natural products and organic compounds. CONSTITUTION: The determination system comprises: a fused expression vector, pNF-k B-SEAP-NPT from fusing a gene expressing NF-kappa B transcription reporter, selected from SEAP(secretory alkaline phosphatase), luciferase, beta-galactosidase and GFP(green fluorescent protein), with a selectable marker expression gene chosen from NPT(neomycin phosphotransferase), CAT(chloramphenicol acetyltransferase) and beta-galactosidase, lacZ; transfecting it to skin cell line; and quantitatively determining the expression of NF-kappa B from the above transfected skin cell line(KCLRF-BP-00035) by fluorometry.

    Abstract translation: 目的:提供人体皮肤细胞中NF-κB表达定量测定的稳定系统及其在筛选皮肤美白剂,抗炎剂或抗氧化剂中的应用。 分析系统使用荧光底物使其非常灵敏和简单,并且有效地用于筛选天然产物和有机化合物中的皮肤增白剂,抗炎剂或抗氧化剂。 构成:测定系统包括:融合表达载体,pNF-k B-SEAP-NPT,其融合表达NF-κB转录报告基因的基因,其选自SEAP(分泌性碱性磷酸酶),荧光素酶,β-半乳糖苷酶和GFP(绿色 荧光蛋白),具有选自NPT(新霉素磷酸转移酶),CAT(氯霉素乙酰转移酶)和β-半乳糖苷酶,lacZ的选择性标记表达基因; 将其转染至皮肤细胞系; 并通过荧光测定定量测定来自上述转染的皮肤细胞系(KCLRF-BP-00035)的NF-κB的表达。

    NF-κB 발현을 인간 피부세포에서 정량적으로 측정하기위한 안정한 분석시스템 및 그의 용도
    2.
    发明授权
    NF-κB 발현을 인간 피부세포에서 정량적으로 측정하기위한 안정한 분석시스템 및 그의 용도 失效
    NF-κB在本发明的一个实施方案中可以包含:NF-κB

    公开(公告)号:KR100414781B1

    公开(公告)日:2004-01-13

    申请号:KR1020000070557

    申请日:2000-11-24

    Abstract: PURPOSE: Provided are stable system for quantitative determination of NF-kappa B expression in human skin cells and its use in screening skin whitening agents, anti-inflammatory agents or anti-oxidants. The analytical system uses fluorescent substrate to make it very sensitive and simple and is used effectively in screening skin whitening agents, anti-inflammatory agents or anti-oxidants in natural products and organic compounds. CONSTITUTION: The determination system comprises: a fused expression vector, pNF-k B-SEAP-NPT from fusing a gene expressing NF-kappa B transcription reporter, selected from SEAP(secretory alkaline phosphatase), luciferase, beta-galactosidase and GFP(green fluorescent protein), with a selectable marker expression gene chosen from NPT(neomycin phosphotransferase), CAT(chloramphenicol acetyltransferase) and beta-galactosidase, lacZ; transfecting it to skin cell line; and quantitatively determining the expression of NF-kappa B from the above transfected skin cell line(KCLRF-BP-00035) by fluorometry.

    Abstract translation: 目的:提供用于定量测定人皮肤细胞中NF-κB表达的稳定系统及其用于筛选皮肤增白剂,抗炎剂或抗氧化剂的用途。 该分析系统使用荧光底物使其非常敏感和简单,并有效地用于筛选天然产品和有机化合物中的皮肤增白剂,抗炎剂或抗氧化剂。 组成:测定系统包括:融合表达NF-κB转录报道基因的融合表达载体pNF-k B-SEAP-NPT,选自SEAP(分泌碱性磷酸酶),萤光素酶,β-半乳糖苷酶和GFP(绿色 荧光蛋白)与选自NPT(新霉素磷酸转移酶),CAT(氯霉素乙酰转移酶)和β-半乳糖苷酶,lacZ的选择标记表达基因; 将其转染至皮肤细胞系; 并通过荧光测定法定量测定来自上述转染的皮肤细胞系(KCLRF-BP-00035)的NF-κB的表达。

Patent Agency Ranking